Institution Information
| Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
|---|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT LLC | 02-14-2024 | 12-31-2023 | 1355 | 4,662,223,648 |
Institutional Holdings
| Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES ANTIMONY CORP | COM | 2251 | $48,680 | 195,500 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| ADMA BIOLOGICS INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -1,580,000 | -99.18 | 12-31-2023 |
| AIM IMMUNOTECH INC | COM | 2253 | $47,905 | 108,900 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
| CIDARA THERAPEUTICS INC | COM | 2254 | $47,688 | 60,060 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
